Digital AI and the Big Data paradigm – big ambitions in novel drug d... Over the past few decades, data generation has veritably exploded.
News Lundbeck drops in on epilepsy drug with $2.6bn Longboard bid Neuroscience specialist Lundbeck has agreed to buy Longboard Pharmaceuticals for $2.6 billion, expanding its pipeline with an epilepsy drug tipped as a future blockbuster.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.
